Jeff is a Dallas-based healthcare executive who has been CEO of three healthcare companies across pharmaceuticals, medical devices, and consumer healthcare since 2008. He is currently an Operating Partner with Texas-based Revival Healthcare Capital, a private equity firm focused on medical devices and medical technology, and is the Managing Partner of Maytal LLC, his personal investment and advisory firm. Jeff also serves on the Board of Directors at Roam Analytics, a Stanford- and venture-backed artificial intelligence healthcare data analytics company based in Silicon Valley.
Between 2008 and 2016, Jeff served on the Executive Committee of Novartis Group, a Fortune 50 pharmaceutical company based in Switzerland, first as Division Head and CEO of Sandoz, Novartis’s $10 billion generic pharmaceuticals and biosimilars subsidiary headquartered in Germany, and then as Division Head and CEO of Texas-based Alcon, Novartis’s then $10 billion eye care subsidiary. In both of his divisional CEO roles at Novartis, Jeff was responsible for leading over 25,000 associates globally across more than 160 countries and had primary line leadership and management responsibility for all functions, regions, and franchises. More recently he served as CEO and Board director of Chicago-based Performance Health, a leader in consumer healthcare and the largest global manufacturer and distributor of products to the physical therapy, sports medicine, and rehabilitation markets.
Earlier in his career, Jeff was head of Emerging Markets for the Middle East, Africa, Southeast Asia and CIS at Novartis Pharmaceuticals, after serving as Vice President and Head of Western & Eastern Europe for Novartis Vaccines. Before joining Novartis, Jeff worked in retail and consumer goods as Senior Director of Strategic Planning & Business Development at Gap Inc., and in management consulting for McKinsey & Company in San Francisco, where he was an Engagement Manager.
Jeff holds an MBA from Harvard University and a master’s degree from Johns Hopkins University’s School of Advanced International Studies (SAIS), where he studied international economics and emerging markets political economy and was a John W. Watzek Fellow. He received his B.A. in international relations, magna cum laude and Phi Beta Kappa, from Carleton College. Jeff served on the Board of Directors for AdvaMed from 2014 to 2016 and since 2012 has been a member of the Young President’s Organization (YPO). He was twice named to Fortune’s “40 under 40” list of up-and-coming leaders. Jeff is married with two daughters and enjoys running, skiing, live music, meditation, yoga, travel, and international affairs.